Videm
VIDEM AB is dedicated to providing accurate, accessible, and affordable disease diagnostics to improve global health. They focus on enabling highly multiplexed and low-cost detection of biomarkers directly at the point of care, with a mission to enhance decision-making, treatment, and health outcomes worldwide.
Industries
biotechnology
clinical-trials
health-diagnostics
Nr. of Employees
small (1-50)
Products
Point-of-care platform for simultaneous nucleic acid and protein detection
A diagnostic platform designed to perform concurrent detection of multiple nucleic acid and protein biomarkers at the point of care, using isothermal amplification integrated with nanotechnology-based biosensing to provide rapid, low-cost results.
Point-of-care platform for simultaneous nucleic acid and protein detection
A diagnostic platform designed to perform concurrent detection of multiple nucleic acid and protein biomarkers at the point of care, using isothermal amplification integrated with nanotechnology-based biosensing to provide rapid, low-cost results.
Services
Collaborative development of point-of-care diagnostics
Partnerships and collaborative R&D to develop multiplexed point-of-care diagnostic assays and sensor platforms.
Collaborative development of point-of-care diagnostics
Partnerships and collaborative R&D to develop multiplexed point-of-care diagnostic assays and sensor platforms.
Expertise Areas
- Point-of-care diagnostics
- Multiplexed assay development
- Nucleic acid detection
- Protein biomarker detection
Key Technologies
- Isothermal amplification
- Multiplexed biosensing
- Nanomaterials-based sensors
- Protein immunoassays